Laspartomycin
| Internal ID | 5f15309a-78ad-4e1d-9dee-40ecb9151310 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides |
| IUPAC Name | (3S)-4-[[(3S,7S,13S,16S,23S,29S,35S)-13-[(2R)-butan-2-yl]-23,29-bis(carboxymethyl)-16-[(1R)-1-hydroxyethyl]-2,6,12,15,18,20,22,25,28,31,34-undecaoxo-1,5,11,14,17,21,24,27,30,33-decazatricyclo[33.4.0.07,11]nonatriacontan-3-yl]amino]-3-[[(E)-13-methyltetradec-2-enoyl]amino]-4-oxobutanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C58H90N12O20/c1-6-33(4)49-58(90)70-24-18-21-40(70)54(86)59-29-38(65-52(84)36(26-47(79)80)62-41(72)22-15-13-11-9-7-8-10-12-14-19-32(2)3)57(89)69-23-17-16-20-39(69)55(87)61-31-45(76)63-35(25-46(77)78)51(83)60-30-44(75)64-37(27-48(81)82)53(85)67-43(74)28-42(73)66-50(34(5)71)56(88)68-49/h15,22,32-40,49-50,71H,6-14,16-21,23-31H2,1-5H3,(H,59,86)(H,60,83)(H,61,87)(H,62,72)(H,63,76)(H,64,75)(H,65,84)(H,66,73)(H,68,88)(H,77,78)(H,79,80)(H,81,82)(H,67,74,85)/b22-15+/t33-,34-,35+,36+,37+,38+,39+,40+,49+,50+/m1/s1 |
| InChI Key | DSQHLPWCVYEPGM-GHJFOLTQSA-N |
| Popularity | 4 references in papers |
| Molecular Formula | C58H90N12O20 |
| Molecular Weight | 1275.40 g/mol |
| Exact Mass | 1274.63943331 g/mol |
| Topological Polar Surface Area (TPSA) | 481.00 Ų |
| XlogP | 0.80 |
| Atomic LogP (AlogP) | -2.76 |
| H-Bond Acceptor | 17 |
| H-Bond Donor | 14 |
| Rotatable Bonds | 23 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.4684 | 46.84% |
| Caco-2 | - | 0.8591 | 85.91% |
| Blood Brain Barrier | - | 0.9500 | 95.00% |
| Human oral bioavailability | - | 0.7286 | 72.86% |
| Subcellular localzation | Mitochondria | 0.5354 | 53.54% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8182 | 81.82% |
| OATP1B3 inhibitior | + | 0.9112 | 91.12% |
| MATE1 inhibitior | - | 0.9446 | 94.46% |
| OCT2 inhibitior | - | 0.9750 | 97.50% |
| BSEP inhibitior | + | 0.9364 | 93.64% |
| P-glycoprotein inhibitior | + | 0.7422 | 74.22% |
| P-glycoprotein substrate | + | 0.8481 | 84.81% |
| CYP3A4 substrate | + | 0.7352 | 73.52% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8830 | 88.30% |
| CYP3A4 inhibition | - | 0.9676 | 96.76% |
| CYP2C9 inhibition | - | 0.9088 | 90.88% |
| CYP2C19 inhibition | - | 0.9254 | 92.54% |
| CYP2D6 inhibition | - | 0.9384 | 93.84% |
| CYP1A2 inhibition | - | 0.9469 | 94.69% |
| CYP2C8 inhibition | + | 0.7125 | 71.25% |
| CYP inhibitory promiscuity | - | 0.9777 | 97.77% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.9400 | 94.00% |
| Carcinogenicity (trinary) | Non-required | 0.6110 | 61.10% |
| Eye corrosion | - | 0.9881 | 98.81% |
| Eye irritation | - | 0.8965 | 89.65% |
| Skin irritation | - | 0.7575 | 75.75% |
| Skin corrosion | - | 0.9066 | 90.66% |
| Ames mutagenesis | - | 0.6854 | 68.54% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3689 | 36.89% |
| Micronuclear | + | 0.7900 | 79.00% |
| Hepatotoxicity | - | 0.5375 | 53.75% |
| skin sensitisation | - | 0.8755 | 87.55% |
| Respiratory toxicity | + | 0.7444 | 74.44% |
| Reproductive toxicity | + | 0.8778 | 87.78% |
| Mitochondrial toxicity | + | 0.9625 | 96.25% |
| Nephrotoxicity | + | 0.4861 | 48.61% |
| Acute Oral Toxicity (c) | III | 0.6077 | 60.77% |
| Estrogen receptor binding | + | 0.7027 | 70.27% |
| Androgen receptor binding | + | 0.7111 | 71.11% |
| Thyroid receptor binding | + | 0.5381 | 53.81% |
| Glucocorticoid receptor binding | + | 0.6323 | 63.23% |
| Aromatase binding | + | 0.6820 | 68.20% |
| PPAR gamma | + | 0.7311 | 73.11% |
| Honey bee toxicity | - | 0.7253 | 72.53% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | + | 0.5100 | 51.00% |
| Fish aquatic toxicity | + | 0.8276 | 82.76% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.87% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.26% | 96.09% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 98.90% | 92.97% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 98.87% | 90.17% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 98.71% | 94.66% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 98.53% | 96.38% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 98.36% | 94.45% |
| CHEMBL236 | P41143 | Delta opioid receptor | 98.16% | 99.35% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 96.83% | 96.11% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 96.62% | 90.08% |
| CHEMBL4071 | P08311 | Cathepsin G | 95.70% | 94.64% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 95.62% | 96.31% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 95.53% | 95.50% |
| CHEMBL1801 | P00747 | Plasminogen | 95.42% | 92.44% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 95.19% | 82.38% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 94.27% | 92.12% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 94.03% | 96.90% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 94.02% | 91.03% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 94.01% | 90.93% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 93.85% | 90.71% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 93.64% | 97.64% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 93.21% | 94.75% |
| CHEMBL4801 | P29466 | Caspase-1 | 92.88% | 96.85% |
| CHEMBL2443 | P49862 | Kallikrein 7 | 92.78% | 94.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 92.60% | 93.56% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 91.95% | 99.17% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.94% | 96.47% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 91.89% | 98.33% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 91.47% | 93.00% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 91.23% | 91.11% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 91.23% | 98.05% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 91.07% | 93.03% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 90.18% | 95.00% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 89.28% | 98.24% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 89.10% | 97.05% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 88.69% | 100.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 87.85% | 97.14% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 87.54% | 90.24% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 87.06% | 85.14% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 86.82% | 94.50% |
| CHEMBL2474 | P53582 | Methionine aminopeptidase 1 | 86.45% | 97.09% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 86.30% | 99.18% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 85.48% | 89.00% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 85.35% | 95.93% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 85.32% | 100.00% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 85.09% | 95.89% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 84.83% | 89.50% |
| CHEMBL3468 | P55210 | Caspase-7 | 84.83% | 95.68% |
| CHEMBL222 | P23975 | Norepinephrine transporter | 84.80% | 96.06% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 84.33% | 95.56% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 83.57% | 94.33% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 83.42% | 97.09% |
| CHEMBL228 | P31645 | Serotonin transporter | 83.34% | 95.51% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 83.31% | 97.86% |
| CHEMBL1781 | P11387 | DNA topoisomerase I | 82.78% | 97.00% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 81.53% | 100.00% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 81.35% | 97.43% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 81.34% | 97.50% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 81.21% | 95.92% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 81.17% | 100.00% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 80.63% | 92.50% |
| CHEMBL2096618 | P11274 | Bcr/Abl fusion protein | 80.56% | 85.83% |
| CHEMBL4633 | P22001 | Voltage-gated potassium channel subunit Kv1.3 | 80.02% | 100.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139589219 |
| LOTUS | LTS0128302 |
| wikiData | Q104401583 |